A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for decades.

The new members of the Advisory Committee on Immunization Practices began their tenure Wednesday by shifting the posture of the 60-year-old panel from support for vaccine advancement to doubt about the safety and efficacy of well-established and widely administered inoculations.